Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Utah Medical Products ( (UTMD) ) has issued an update.
On May 1, 2026, Utah Medical Products stockholders voted on key governance and compensation matters at the company’s annual meeting, including the election of directors, ratification of the auditor, and an advisory say-on-pay resolution. Shareholders elected Ernst G. Hoyer and James H. Beeson to the board and strongly ratified Haynie & Co. as the independent public accounting firm for the fiscal year ending December 31, 2026, signaling broad support for the company’s oversight structure.
Investors also approved on an advisory basis the compensation program for the company’s named executive officers, indicating continued backing for existing pay practices and leadership incentives. The company committed to maintaining annual advisory votes on executive compensation at least until the next required vote on the frequency of such say-on-pay ballots, reinforcing an ongoing framework for shareholder input into governance and pay policies.
Spark’s Take on UTMD Stock
According to Spark, TipRanks’ AI Analyst, UTMD is a Neutral.
The score is mainly constrained by deteriorating TTM cash flow and ongoing revenue declines despite strong margins, while an exceptionally conservative balance sheet provides stability. Technical indicators point to a weak downtrend (oversold but still bearish), and valuation is reasonable but not sufficiently compelling to outweigh the fundamental pressures.
To see Spark’s full report on UTMD stock, click here.
More about Utah Medical Products
Utah Medical Products operates in the medical device industry, focusing on products used in obstetrics, gynecology, neonatal intensive care, and other specialized hospital and clinical settings. The company targets healthcare providers and institutions that require reliable, regulated devices to support women’s health and neonatal care, positioning itself in a niche segment of the broader medical technology market.
Average Trading Volume: 14,888
Technical Sentiment Signal: Buy
Current Market Cap: $209.5M
See more insights into UTMD stock on TipRanks’ Stock Analysis page.